Cyclic thioether peptide mimetics as VCAM-VLA-4 antagonists

被引:29
作者
Fotouhi, N [1 ]
Joshi, P [1 ]
Tilley, JW [1 ]
Rowan, K [1 ]
Schwinge, V [1 ]
Wolitzky, B [1 ]
机构
[1] Hoffmann La Roche Inc, Roche Res Ctr, Nutley, NJ 07110 USA
关键词
D O I
10.1016/S0960-894X(00)00175-X
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Selective substitution of a sulfur atom by carbon in a highly potent 13-membered cyclic disulfide was accomplished by intramolecular displacement of a bromide. The potency of the resulting thioethers in the VCAM/VLA-4 assay was dependant on rin size and the position of the sulfur atom. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1167 / 1169
页数:3
相关论文
共 8 条
[1]  
CHEN L, 1999, Patent No. 10312
[2]  
ELICES M, 1999, CURR OPIN ANTIINFLAM, V1, P14
[3]  
ELICES MJ, 1998, CELL ADHESION MOL MA, P133
[4]   The design and synthesis of potent cyclic peptide VCAM-VLA-4 antagonists incorporating an achiral Asp-Pro mimetic [J].
Fotouhi, N ;
Joshi, P ;
Fry, D ;
Cook, C ;
Tilley, JW ;
Kaplan, G ;
Hanglow, A ;
Rowan, K ;
Schwinge, V ;
Wolitzky, B .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (11) :1171-1173
[5]   Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents [J].
Jackson, DY ;
Quan, C ;
Artis, DR ;
Rawson, T ;
Blackburn, B ;
Struble, M ;
Fitzgerald, G ;
Chan, K ;
Mullins, S ;
Burnier, JP ;
Fairbrother, WJ ;
Clark, K ;
Berisini, M ;
Chui, H ;
Renz, M ;
Jones, S ;
Fong, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (21) :3359-3368
[6]   Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents [J].
Lin, KC ;
Castro, AC .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) :453-457
[7]   Selective, tight-binding inhibitors of integrin α4β1 that inhibit allergic airway responses [J].
Lin, KC ;
Ateeq, HS ;
Hsiung, SH ;
Chong, LT ;
Zimmerman, CN ;
Castro, A ;
Lee, WC ;
Hammond, CE ;
Kalkunte, S ;
Chen, LL ;
Pepinsky, RB ;
Leone, DR ;
Sprague, AG ;
Abraham, WM ;
Gill, A ;
Lobb, RR ;
Adams, SP .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (05) :920-934
[8]  
Lobb R R, 1999, Expert Opin Investig Drugs, V8, P935, DOI 10.1517/13543784.8.7.935